Remission of the newly diagnosed type 1 diabetes by radiation of the pancreas.

Exp Clin Endocrinol

First Clinic of Internal Medicine, County Hospital Friedrich Wolf, Karl-Marx-Stadt/DDR.

Published: September 1988

The process of autoaggression of the IDDM causes an "insulitis" leading to the destruction of the beta-cells. By photons (9 MV) in a total dose of 10 Gy, divided into 5 single doses at an interval of 2 days in each case we could get a total remission in 3 out of 4 diabetics, a partly remission in the fourth patient. The therapeutic effect lasts till now (1-6 months) without any further treatment. The combination of a radiation of 5 x 1 Gy with 1 mg methylprednisolon/kg body weight at the beginning of the treatment leads to a partly remission in 5 out of 7 patients lasting 3-7 months hitherto. Beside the antiinflammatory effect of the radiation on the "insulitis" an effect on the activated lymphocytes can be supposed. Side effects were not observed. They need not to be expected in a local therapy in a relatively small field size with a low radiation dose. Further research is necessary to confirm the results.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0029-1210792DOI Listing

Publication Analysis

Top Keywords

partly remission
8
remission
4
remission newly
4
newly diagnosed
4
diagnosed type
4
type diabetes
4
radiation
4
diabetes radiation
4
radiation pancreas
4
pancreas process
4

Similar Publications

Background: Fatigue is common among patients with inflammatory bowel diseases (IBDs) and is associated with decreased quality of life (QoL).

Aims: Describe fatigue evolution and identify factors associated with fatigue outcomes in patients with ulcerative colitis (UC) or Crohn's disease (CD) initiating biologic treatment.

Methods: Data from adult Belgian patients with UC or CD enrolled in a prospective real-world study were utilized.

View Article and Find Full Text PDF

Increased structural covariance of cortical measures in individuals with an at-risk mental state.

Prog Neuropsychopharmacol Biol Psychiatry

November 2024

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama city, Toyama 930-0194, Japan; Research Center for Idling Brain Science, University of Toyama, 2630 Sugitani, Toyama city, Toyama 930-0194, Japan.

An anomalous pattern of structural covariance has been reported in schizophrenia, which has been suggested to represent connectome changes during brain maturation and neuroprogressive processes. It remains unclear whether similar differences exist in a clinical high-risk state for psychosis, and if they are associated with a prodromal phenotype and/or later psychosis onset. This multicenter magnetic resonance imaging study cross-sectionally examined structural covariance in a large at-risk mental state (ARMS) sample with different outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • Asparaginase is crucial in treating pediatric acute lymphoblastic leukemia (ALL) but can lead to complications like asparaginase-associated pancreatitis (AAP), with genetic factors influencing this risk.
  • A case study of a 4-year-old girl diagnosed with B-cell ALL revealed AAP after starting treatment, linked to a specific genetic variant associated with increased pancreatitis susceptibility.
  • The patient's pancreatitis was managed effectively, and she achieved complete remission through an asparaginase-free treatment plan, highlighting the importance of genetic screening for improved patient outcomes.
View Article and Find Full Text PDF

In rheumatoid arthritis (RA), the risk of cardiovascular death is 50% higher compared to the general population. This increased risk is partly due to the systemic inflammation characteristic of RA and changes in the lipoprotein profiles. This study investigated plasma lipid levels, lipid ratios, and the composition and functionality of high-density lipoprotein (HDL) in control individuals and RA subjects based on the disease's inflammatory score (DAS28).

View Article and Find Full Text PDF

In rheumatoid arthritis (RA), the identification of prognostic factors (PF) capable of predicting disease outcome, response to treatment or success of dose reduction is an important issue, as these factors are intended to serve as a basis for decision-making. The task is complex from the outset, as the definition of disease prognosis or therapeutic prognosis is not uniquevocal. The heterogeneity of the definitions used partly explains the failure to identify PF that can be applied at an individual level.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!